FDA slaps nvs......again!

























Ant again...who pays the price of greed? Yep...the reps and others who are low on the totem pole. Thanks Management...hope you can sleep well at night knowing the decisions YOU made have hurt several people and their families

These are the risks of the business of medicine. The business YOU decided to be a part of.
 






These are the risks of the business of medicine. The business YOU decided to be a part of.

"This is the business we chose...I didn't ask who gave the order. It was business not personal".
Is this what Novartis came to? FU for suggesting that reps and other employees willingly and knowingly bacome part of mafia-like biz. Yes it is mafia like but we who joined with good intentions and hopes did not know or were told we are entering Novamafia family.
At least with the "other" mafia you know what they are and who you are dealing with.
And since you are part of this mafia family, remember OMERTA is the word.
CAPISHE?
 






from the article "For Novartis, the FDA focused on a "Case Highlights" document that described how well Gleevec worked for a particular patient. The FDA said this was misleading because the document implied the drug would work just as well for other patients"

This is BS, if you are looking for information about a product and see "case highlights" and how something worked for a particluliar patient, you assume it would work exactly the same way for you---your an idiot. FDA overstepping
 






from the article "For Novartis, the FDA focused on a "Case Highlights" document that described how well Gleevec worked for a particular patient. The FDA said this was misleading because the document implied the drug would work just as well for other patients"

This is BS, if you are looking for information about a product and see "case highlights" and how something worked for a particluliar patient, you assume it would work exactly the same way for you---your an idiot. FDA overstepping

No the FDA isn't overstepping. Novartis Brand leadership in all quadrants regularly fails to give emphasis to what doesn't work - and consistently promotes only the miraculous responses. Look at their brochures - count the number of positive comments/charts/graphs vs reactions/side effects/and not so good outcomes.

Selling Snake Oil is what Pharmaceutical companies do best - and they are masters at misleading physicians on important information they know MDs are not likely to seek out on their own.

I know at meetings we're all coached to give fair balance, but rarely have I ever witnessed a Rep. making that effort. Most Reps can't hold a candle to the disease state their product treats compared to the physician's medical and practical empirical knowledge base. Most Reps just BS their way through the positive and hope like hell the MD just sits there and agrees enough to sign a sample form in front of their smiling RMs.

It would be far better for the companies to train their Reps on the side effect management of their products (teach them at least to know what a side effect is) so they could help teach the RNs on supportive care for when their product causes the patient to vomit, double up in cramps, go blind or whatever it is their drug does. God it would be so helpful if a company would just teach their reps to understand statistics how they are collected, compiled, and managed. I ride along with senior Reps that have no idea why their drug might have a high cardiovascular component to it (pharmacokinetics) - and how that particular side effect doesn't really say how much different it is from something more serious - or what was the patient experiencing - what type of patients are more likely to experience it.

This industry is plowing it's own field of destruction. Most reps I've ridden with over the years can't even pronounce medical conditions they're suppose to be treating with their products.

I'm am utterly amazed that MDs even let us in the office anymore. If it weren't for free lunches I doubt many of them would.
 






Yeah it would be interesting to show a good outcome on product and a bad outcome as well.
One picture of Granny playing tennis, an another of Granny on a gurney vomiting her guts out.

Somewhere between the two a physician might think twice instead of being misled by Granny playing tennis because he Rx this pill.